Antigens from Streptococcus mutans were examined to identify specific polypeptides that may have stimulated antibody responses and possibly play some role in caries immunity. A group of 10 adult human subjects was screened for serum antibodies reactive with antigens from S. mutans. Extracellular and cellular protein preparations from S. mutans LM7 (Bratthall serotype e) and V403 (biotype c) were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by Western electrophoretic transfer and immunoblotting analysis. Antibodies reactive with polypeptides ranging from 34 to 400 kilodaltons in apparent molecular mass were detected by these means. Radioimnmunoassay competition experiments revealed that the cellular and extracellular antigens did not compete with each other for serum antibodies. Preabsorption of sera with extracellular proteins from other oral streptococcal species prior to immunoblotting indicated that the antigens unique to S. mutans have molecular masses greater than 100 kilodaltons, and each individual produced antibodies against different antigens of high molecular mass. Examination of sera from young children also indicated heterogeneous responses against S. mutans LM7 antigens.
Dental caries continues to be a major health problem in the world today (8) . Animal models have implicated Streptococcus mutans as the primary etiological agent (5, 6, 11) . Since more than 99% of individuals in western nations develop caries, innate immune mechanisms are apparently ineffective. Though dental caries is prevalent in children, most adult humans have low incidences of dental caries. This suggests that some type of immunity might be acquired by early adulthood. Significant antibody titers in saliva and serum are present in most adult humans and have been shown to be induced by oral immunization with S. mutans (7, 17) . Animal model systems have been used extensively to investigate the immunogenicity of S. mutans. For example, oral immunization with killed S. mutans has been shown to induce secretory immunoglobulin A (IgA) and caries immunity in rodents (18) . Serum antibodies (IgG, IgM, and IgA classes) have also been demonstrated in response to whole cells, crude cell wall preparations, and extracellular proteins including glucosyltransferase in monkeys and rats (14, 21, 24) . In some instances, these elevations in antibody titers have been associated with effective immunity (19, 23) . Specific surface antigens which have been associated with immunity in animals include the spaA protein (R. Curtiss III, R. G,oldschmidt, J. Barret, W. Jacobs, R. Pastian, M.
Lyons, S. M. Michalek, and J. Mestecky, in S. Hamada The purpose of this study was to identify specific antigens from S. mutans which have stimulated a potentially protective antibody response in the sera of an adult human populations. We were able to detect antibodies to cellular and extracellular antigens of S. mutans by Western blot analyses. These antigens were checked for shared immunodeterminants with extracellular proteins from other * Corresponding author. oral streptococci. We contrasted early antibody responses in humans by using the sera of young children to compare with profiles of adults. The results described here indicate heterogeneity in the immune responses of both young children and adults.
MATERIALS AND METHODS Antisera. Human sera were obtained by venipuncture from nine adults with a normal array of carious lesions and from one caries-free adult. Two adult New Zealand White rabbits were inoculated intramuscularly with 800 ,ug of S. mutans LM7 extracellular protein emulsified in an equal volume of Freund complete adjuvant. The rabbits were boosted 1 month later with the same amount of protein without adjuvant and bled 2 weeks after the booster.
Bacterial strains and medium. S. mutans LM7 (Bratthall serotype e) and V403 (serotype c) and S. sanguis V288 have been previously described (20) . S. mitis 118 and S. salivarius I1 were clinical isolates obtained from D. LeBlanc (9) . S. faecalis JH2-2 was obtained from D. Clewell. Streptococci were grown in chemically defined FMC medium (25) .
Preparation of streptococcal protein fractions. Streptococcal protein fractions were obtained as previously described (20) . Strains were grown aerobically for 24 to 36 h at 37°C in 1 liter of chemically defined medium (25; glucose was the carbon source) supplemented with 10 mM sodium bicarbonate. Cells were harvested by centrifugation at 9,000 x g for 20 min in an Ivan Sorvall, Inc. (Norwalk, Conn.) GSA rotor. The washed cells were suspended in 10 ml of 10 mM sodium phosphate buffer (pH 6.5) and mechanically broken in a Bead-Beater (Biospec Products, Inc., Bartlesville, Okla.). This was followed by centrifugation of unbroken cells and cell debris at 300 x g and retention of the supernatants.
These constituted the cellular fractions. The extracellular fractions consisted of ammonium sulfate (60% saturated) precipitations of the 1-liter culture supernatants at 4°C. The precipitates were suspended in 10 ml of 10 10 ,ug/ml. The antibodyantigen mixtures then were centrifuged at 12,000 x g in an Eppendorf microcentrifuge (Brinkmann Instruments, Inc., Westbury, N.Y.) for 5 min to remove immune complexes and any other insoluble material. These preadsorbed sera then were used to provide the first antibodies in immunoblot experiments as described above. RESULTS Identification of immunogenic S. mutans extracellular proteins. S. mutans LM7 (Bratthall serotype e) and V403 (serotype c) cellular and extracellular proteins were resolved on SDS-polyacrylamide gels. Figure 1 shows the resulting protein profiles visualized by Coomassie blue staining. Several proteins in both fractions had apparent molecular masses of greater than 100 kilodaltons. This size is in the range reported for glucosyltransferases from several S. mutans serotypes (3) . Extracellular proteins from S. miutans LM7 (Fig. 1 , lane B) were used to immunize rabbits in an attempt to determine which of these antigens could elicit an antibody response. Immune serum from these rabbits was tested via immunoblotting (27) . S. mitans LM7 extracellular proteins were subjected to SDS-PAGE and transferred by Western blotting (28) to nitrocellulose paper. The nitrocellulose paper then was immunoblotted with hyperimmune rabbit serum as the first antibody and goat anti-rabbit antibody coupled to horseradish peroxidase as the second antibody. The resulting immunoreactive antigens are displayed in Fig. 2 Human serum antibody response against S. mutans antigens. We next were interested in the number and identity of S. mutans antigens to which an antibody response has been mounted in a human adult population. Human serum samples were obtained from 10 adult subjects, including 1 individual who was caries free. The 10 serum samples were screened for antibodies against S. mutans LM7 and V403 cellular and extracellular antigens. The S. mutans proteins were run on SDS-polyacrylamide gels, immobilized on nitrocellulose paper via Western transfer, and immunoblotted with serum from each of the 10 subjects. Equal dilutions of serum were used in each experiment. Figure 3 illustrates the results for six of the adult subjects. Two to 5 cellular immunoreactive polypeptides were visible in these individuals, while 5 to 17 extracellular polypeptides were recognized by serum antibodies. At least three common immunoreactive polypeptides were present among all 10 adults and for both strains. These included two cellular polypeptides of approximately 59 and 61 kilodaltons (Fig. 3 , asterisks) and one extracellular polypeptide of approximately 57 kilodaltons (Fig. 3, arrow) . There also appeared to be differences in immunoreactive polypeptides of higher molecular mass (>100 kilodaltons). No obvious major differences in immunoreactivity were observed between the caries-free individual (Fig. 3, panel 3 ) and the other nine adult subjects except in the higher-molecular-mass range.
Specificity of antigen: competition experiments. The cellular and extracellular antigens of S. mutans LM7 and V403 were examined to determine if there were any common immunodeterminants among these proteins. This was done by a competition experiment (Fig. 4) by which the indicated target antigen, either cellular or extracellular LM7 protein was allowed to coat wells of a microtiter plate. Each of the two potential competing antigens against either cellular or extracellular LM7 protein was mixed with equivalent amounts of human serum from a subject picked at random. Formation of antibody-antigen complexes should effectively reduce antibody available for interaction with the immobilized target antigens. LM7 cellular antigens successfully competed with immobilized LM7 cellular antigens, while LM7 extracellular antigens were unable to exhibit a comparable effect against cellular antigens (Fig. 4) . In the reverse situation, in which the LM7 target antigens were extracellular, no competition was observed from LM7 cellular antigens. These data indicated that there was little crossreactivity between the cellular and extracellular antigens of S. mutans LM7. Similar results were obtained with S. mutans V403 (data not shown).
Cross-reactivity of bacterial antigens. The immunoreactive proteins recognized by the human sera may not have been unique to S. mutans but might have represented immunodeterminants present in other streptococcal species.
To investigate this possibility, we obtained extracellular preparations of three other oral streptococci, S. sanguis, S. salivarius, and S. mitis, as well as S. faecalis. Each of these protein preparations was incubated at various concentrations with human serum overnight. The absorbed sera were then added to the target antigens, S. mutans LM7 extracellular proteins, and serum antibody binding was determined Proteins were subjected to SDS-PAGE with a 10% acrylamide slab gel followed by electrophoretic transfer to nitrocellulose paper. The paper was reacted with serum from a rabbit immunized with an S. mutans LM7 extracellular antigen preparation. Goat anti-rabbit antibody coupled to horseradish peroxidase was then added, followed by immersion in color development solution to visualize immunoreactive bands. Major bands for LM7 were 56, 79, 86, 125, 140, and 323 kilodaltons; for V403 they were 58, 82, 133, and 154 kilodaltons.
with I125-labeled goat anti-human antibody. Binding of human serum antibodies to S. mutans LM7 extracellular antigens was affected in three ways (Fig. 5) . First, there was little or no inhibition of binding, with S. faecalis protein (except at the high dose range) as an example. Second, there was partial inhibition of binding when S. mitis antigens were used in preincubation. Finally, almost total inhibition of binding could be achieved by using S. mutans extracellular proteins in preincubation.
The immunoblots (Fig. 6 ) further illustrate the crossreactivity of certain antigens among the oral streptococci. Proteins were subjected to SDS-PAGE with a 10% acrylamide slab gel followed by electrophoretic transfer to nitrocellulose paper. Human serum was incubated with the following extracellular protein preparations at 10 pLg/ml before incubation with the nitrocellulose paper followed by addition of goat anti-rabbit antibody coupled to horseradish peroxidase and immersion in color development solution for immunoreactive band visualization. Lanes: A, control; B, S. sanguis; C, S. mitis; D, S. salivyarius; E, S. 
DISCUSSION
The work described here indicates that there are a variety of S. mutans antigens to which serum antibodies are produced in humans. The humoral immune system is probably exposed to S. mutans antigens through minor cuts and abrasions in gingival tissue which can occur during dental procedures and probably during routine brushing and cleaning of teeth. At least three antigens appeared to be common in each of the 10 adult subjects in this study. These included cellular antigens of 59,000 and 61,000 daltons and an extracellular antigen of about 57,000 daltons. The cellular antigens are in the size range of the natural antigen recently reported (Russell et al., in press) as a wall protein which cross-reacts with other oral bacteria besides S. mutans. Although the predominant antibodies were directed against similar-molecular-mass antigens below 100,000 daltons in each of the adult serum samples examined, differences appeared in responses to antigens greater than 100,000 daltons in molecular mass. This latter observation may have significance in caries development, since most of the glucosyltransferases studied thus far have molecular masses above 100,000 daltons (3), and it has been demonstrated in animals that antibodies against glucosyltransferases can confer protection against the development of dental caries. The caries-free adult subject showed no obvious differences in the immunoblot profiles except in the area above 100,000 kilodaltons molecular mass, where individuals appear to display immunoreactivity against a variety of polypeptides (Fig. 3) .
There seem to be immunologically distinct antibodies against extracellular and cellular antigens of S. mutans in human serum, as competition experiments indicated (Fig. 4) . If shared immunodeterminants were present and equally accessible, serum antibodies would be titrated out and unable to bind to the target antigens. This did not occur with either S. mutans LM7 or V403 when extracellular antigens were mixed with serum and then added to cellular target antigens or in the reverse situation, in which cellular antigens were mixed with serum and then added to extracellular target antigens.
The use of sera from rabbits which had been immunized with S. mutans LM7 extracellular proteins suggested the potential immunogenicity of many of these proteins. Figure  2 illustrates that there are at least 25 detectable immunoreactive polypeptides from LM7, ranging from approximately 24,000 to 320,000 daltons. S. mutans V403 had 13 detectable immunoreactive polypeptides when screened with antisera to LM7 extracellular antigens, which ranged from about 40,000 to 360,000 daltons. These presumably represent antigens cross-reactive with those of LM7. We believe that these data show that there are several proteins of S. mutans which can be potentially immunogenic and that at least a few seem to be strongly immunoreactive or cross S. mutans serotypes or both, at least in this rabbit system. Figures 5 and 6 indicate that some of the antigens of S. mutans are similar immunologically to those of some other oral streptococci. S. salivariuis seems to share the fewest common determinants, with S. sanguis sharing the most immunodeterminants. S. mitis seems to lie somewhere between these two. These results were not surprising, since cross-reactive antigens have been reported among the oral streptococci (22) . Figure 6 indicates that the least crossreactivity lies in the high-molecular-mass region above 100,000 daltons. These data do not prove that these antigens are unique to S. mutans, since there are many other microorganisms to consider, but the number of antigens which do share determinants are probably not protective and can be ruled out as prime vaccine candidates.
Since caries occurs far less frequently in adults, it is possible that caries immunity is eventually acquired over a long time. The sera of five young children 8 to 26 months old were examined for antibodies against S. mutans extracellular antigens. The results indicated some similarities in the immunoblot profiles below about 60,000 daltons as early 10 months old. However, as in adults, differences in reactivity to the high-molecular-mass antigens were seen, and one child appeared to have few, if any, antibodies to S. mutans extracellular proteins. It is interesting that antibodies reactive with S. mutans antigens are present as early as 8 months of age in some individuals, which is not long after initial tooth eruption and subsequent S. mutans colonization (13) . Since almost all young children eventually acquire carious lesions, these early immunoreactive antigens are presumably not protective.
The human antibodies described in this paper are of the IgG class, since goat anti-human IgG antibody was used as the second antibody in the immunoblot assays. We have made no attempt to determine which antibody classes other than IgG are present in human serum against S. mutans antigens. We have also not looked at secretory IgA responses against specific S. mutans proteins. Some studies have demonstrated significant secretory IgA response against S. mutans (16, 17) , and this may be a major immune response to this pathogen. However, other work has suggested that serum IgG antibodies can move into saliva via crevicular fluid and provide protection (1, 2, 14) .
We believe that the work described here can have implications for development of vaccine against this organism in humans. First, it is evident that humans develop antibodies against many S. mutans proteins from an early age and that these antibodies do not seem to effect immunity, since more than 99% of the population eventually develop caries. Therefore, any of these proteins probably would not be vaccine candidates. Also, many of these S. mutans proteins crossreact immunologically with proteins of other oral streptococci. These proteins also would not make good vaccine candidates, since they are shared by other normal oral flora. We suggest using pools of adult human sera absorbed with a mixture of proteins from other oral streptococci when searching for immunogenic S. mutans proteins. Antigens detected by these serum pools then should be checked for reactivity with a pool of sera from young children. Antigens which react with the pooled adult sera but not with the pooled child sera should be further studied. Finally, there appeared to be several S. mutans extracellular proteins to which antibody was produced in the immunized rabbit but not in the human subjects. This many indicate that some S. mutans proteins are poor immunogens under normal circumstances but can be good immunogens if appropriate doses are used during immunization. Some of these are highmolecular-mass proteins over 100,000 in molecular mass.
We have begun to clone immunoreactive proteins of S. 605 VOL. 51, 1986 on August 14, 2017 by guest http://iai.asm.org/ Downloaded from mutans LM7 which are reactive to either human serum or hyperimmune rabbit serum. This is presently being done with a genomic library consisting of Escherichia coli cells containing the plasmid pOP203 (A2) with S. mutans chromosomal DNA inserts (20) . We are also screening bacteriophage lambda libraries with each type of serum. The cloned immunoreaictive proteins will be further examined individually as potential immunogens for vaccines against S.
mutans. Since S. mutans antigen(s) appears to be crossreactive with human heart tissue (4, 10), each of the cloned proteins can be screened for this property also. This approach may also aid in identifying proteins which have thus far not been cloned successfully from this organism (i.e., some glucosyltransferases). Such molecular genetic approaches should eventually allow the production of a safe and efficacious vaccine against dental caries.
